35 /100
MEDIUM RISK
Score updated Jun 14, 2026

ITRMF — Iterum Therapeutics plc Dilution Risk Tracker

Track ITRMF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ITRMF — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
5
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.05 below $1 exchange minimum
🔔 Track ITRMF — Get forecast alerts →

💹 Market Data

Market Cap$4.21M
Shares Outstanding44.66M
FloatN/A
Cash$11.00M
Debt$13.08M
Short InterestN/A

🏛 Institutional Holdings

5.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track ITRMF for full holder detail →

📉 Short Interest

Short Interest1.12M
Days to Cover2.9
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Apr 28, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ITRMF Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ITRMF — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for ITRMF
📊 ITRMF FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ITRMF Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.